Adam Croft

Dr.

Accepting PhD Students

PhD projects

Dr Croft's main research interest is in the development of novel immunotherapies for patients with autoimmune rheumatic and chronic inflammatory diseases. He has a particular interest in the development of stromal cell specific targets. His clinical interests include management of both early and treatment resistant inflammatory arthritis. He is also interested in the management of rare systemic inflammatory diseases including vasculitis.

PhD opportunites are available within the Rheumatology Research Group

20022024

Research activity per year

Network

Andrew Filer

Person: Academic

Karim Raza

Person: Academic

Benjamin Fisher

Person: Academic

Helen McGettrick

Person: Academic

Rowan Hardy

Person: Academic

David Thickett

Person: Academic

Philip Newsome

Person: Academic

Gary Reynolds

Person: Academic, Honorary

Lorraine Harper

Person: Academic

Ingrid Dumitriu

Person: Academic

Ruchir Singh

Person: Academic, Honorary

Michael B. Brenner

  • Harvard Medical School
  • BRIGHAM AND WOMEN'S HOSPITAL

External person

Soumya Raychaudhuri

  • University of Manchester
  • BRIGHAM AND WOMEN'S HOSPITAL

External person

Arif B Ekici

  • University of Erlangen
  • Bilkent University

External person

Christina Simoglou Karali

  • University of Oxford

External person

Bethan Psaila

  • University of Oxford
  • Churchill Hospital

External person

Gerald F M Watts

  • Harvard Medical School
  • BRIGHAM AND WOMEN'S HOSPITAL

External person

Martha Cedeño

  • University of California, San Diego

External person

Juan D. Cañete

  • Universitat de Barcelona

External person

Gary S. Firestein

  • University of California, San Diego

External person

Filipa Costa Simões

  • University of Oxford

External person

Laura T. Donlin

  • Hospital for Special Surgery - New York
  • Weill Cornell Medicine in Qatar

External person

Caroline Ospelt

  • University of Zurich

External person

Dylan Windell

  • University of Oxford

External person

Johannes Knitza

  • University Hospital of Erlangen

External person

Eric Chang

  • University of California, San Diego

External person

Marta Sala-Climent

  • University of California, San Diego

External person

Neil C Henderson

  • University of Edinburgh

External person

David Leonard Huso

  • Department of Molecular and Comparative Pathobiology, The Sidney Kimmel Comprehensive Cancer Center, John Hopkins Medical Institutions, Baltimore, Md.

External person

Wei Xiong Wen

  • University of Oxford

External person

Oswald Quehenberger

  • VA San Diego Healthcare System

External person

Guanlin Wang

  • University of Oxford

External person

S P Brooks

  • University of Southampton

External person

M. S. Cooper

  • University of Sydney

External person

Heiko Bruns

  • Universitätsklinikum Erlangen

External person

Kellie R. Machlus

  • Harvard Medical School

External person

Aaron Armando

  • VA San Diego Healthcare System

External person

Ivan O Rosas

  • Baylor College of Medicine

External person

Emily A. Cutler

  • Imperial College London

External person

Adele K. Fielding

  • Imperial College London

External person

Lauren C. Murphy

  • University of Oxford

External person

Marina Vivero

  • Harvard Medical School

External person

Claire Marie Isacke

  • The Institute of Cancer Research

External person

Douglas T. Fearon

  • University of Cambridge

External person

Andrew P. Stone

  • Harvard Medical School

External person

Abha Singh

  • University of California, San Diego

External person

Nikolaos Sousos

  • University of Oxford
  • Churchill Hospital

External person

Rebecca E. Ling

  • University of Oxford

External person

Harris Perlman

  • Northwestern University

External person

Lynette M. Sholl

  • BRIGHAM AND WOMEN'S HOSPITAL

External person

Rachel Jones

  • University of Birmingham

External person

Y. Kim

  • Yonsei University

External person

Steffen Gay

  • University of Zurich

External person

Chrissy Bolton

  • University of Oxford
  • Queen Elizabeth Hospital

External person

Peter John

  • University College London Hospitals NHS Foundation Trust

External person

Hannah Louise Morris

  • Queen Elizabeth Hospital Birmingham

External person

Xi Chen

  • National Center for Toxicological Research

External person

Gill Norman

  • University of Manchester

External person

Andrew D. Dick

  • National Institute for Health Research
  • University of Bristol

External person

Anindita Roy

  • University of Oxford

External person

Antonio Rodriguez-Romera

  • University of Oxford

External person

Joyce B. Kang

  • Stanford University

External person

Michela Colombo

  • University of Oxford

External person

Julio Ramirez

  • Hospital Clínic of Barcelona

External person

Aude Anais Olijnik

  • University of Oxford

External person

Sarah Gooding

  • University of Oxford
  • Churchill Hospital

External person

Natalina E. Elliott

  • University of Oxford

External person